Page 103 - Characterization of genetic neurodevelopmental disorders at adult age, with a focus on 22q11.2 deletion syndrome - Emma Boersma

Parkinsonism in GNDs
17. Foo JN, Lee J, Tan LC, Liu J, Tan EK. Large 3-Mb deletions at 22q11.2 locus in Parkinson’s
disease and schizophrenia. Mov Disord. Dec 2016;31(12):1924-1925. doi:10.1002/mds.26822
18. Clayton PT, Smith I, Harding B. Subacute combined degeneration of the cord, dementia and
Parkinsonism due to an inborn error of folate metabolism. Journal of Neurology Neurosurgery
and Psychiatry. 1986;49(8):920-927.
19. Fan SP, Lee NC, Lin CH. Novel Phenotype of 6p25 Deletion Syndrome Presenting Juvenile
Parkinsonism and Brain Calcification. Mov Disord. May 5 2020;doi:10.1002/mds.28079
20. Park J, Park ST, Kim J, Kwon KY. A case report of adult-onset Alexander disease clinically
presenting as Parkinson’s disease: is the comorbidity associated with genetic susceptibility?
BMC Neurol. Jan 17 2020;20(1):27. doi:10.1186/s12883-020-1616-8
21. Sechi GP, Conti M, Sau GF, Cocco GA. Valproate-induced parkinsonism, glial cells and
Alexander’s disease. Prog Neuropsychopharmacol Biol Psychiatry. Jul 1 2008;32(5):1351-2.
doi:10.1016/j.pnpbp.2008.03.022
22. Vazquez-Justes D, Penalva-Garcia J, Lopez R, Mitjana R, Begue R, Gonzalez-Mingot C.
Parkinsonism phenotype in a family with adult onset Alexander disease and a novel mutation
of GFAP. Clin Neurol Neurosurg. May 6 2020;195:105893. doi:10.1016/j.clineuro.2020.105893
23. Yoshida T, Sasayama H, Mizuta I, et al. Glial fibrillary acidic protein mutations in adult-onset
Alexander disease: clinical features observed in 12 Japanese patients. Acta Neurol Scand. Aug
2011;124(2):104-8. doi:10.1111/j.1600-0404.2010.01427.x
24. Harbord M. Levodopa responsive Parkinsonism in adults with Angelman Syndrome. J Clin
Neurosci. Sep 2001;8(5):421-2. doi:10.1054/jocn.2000.0753
25. Woodward K, Bhatti D, Rush E. First reported case of parkinsonism in a patient with
argininosuccinate lyase deficiency. Movement Disorders. 2017;32(Supplement 2):703-704.
21st International Congress of Parkinson’s Disease and Movement Disorders. Canada.
doi:http://dx.doi.org/10.1002/mds.27087
26. Akcakaya NH, Salman B, Gormez Z, et al. A Novel and Mosaic WDR45 Nonsense Variant
Causes Beta-Propeller Protein-Associated Neurodegeneration Identified Through Whole
Exome Sequencing and X chromosome Heterozygosity Analysis. Neuromolecular Med. Mar
2019;21(1):54-59. doi:10.1007/s12017-018-08522-6
27. Hornemann F, Le Duc D, Roth C, Pfaffle R, Huhle D, Merkenschlager A. Childhood Dystonia-
Parkinsonism Following Infantile Spasms-Clinical Clue to Diagnosis in Early Beta-
Propeller Protein-Associated Neurodegeneration. Neuropediatrics. Feb 2020;51(1):22-29.
doi:10.1055/s-0039-1696688
28. Kumada S, Hayakawa I, Nakata Y, et al. A functional neuroradiological study in an adult case
of betapropeller protein-associated neurodegeneration. Movement Disorders. 2015;30(SUPPL.
1):S384-S385. 19th International Congress of Parkinson’s Disease and Movement Disorders.
San Diego, CA United States.(var.pagings). doi:http://dx.doi.org/10.1002/mds.26295
29. Machado D. Genetic testing for beta-propeller protein-associated neurodegeneration (BPAN).
Neurology. 2017;88(16 Supplement 1)69th American Academy of Neurology Annual Meeting,
AAN 2017. United States.
30. Ohi K, Kageyama Y, Ichikawa K, Nishioka K. Clinical investigation of beta-propeller protein
associated neurogeneration (BPAN). Journal of the Neurological Sciences. 2017;381(Supplement
1):701-702. 23rd World Congress of Neurology, WCN 2017. Japan. doi:http://dx.doi.
org/10.1016/j.jns.2017.08.1975
31. Fonderico M, Laudisi M, Andreasi NG, et al. Patient Affected by Beta-Propeller Protein-
Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy. Front
Neurol. 2017;8:385. doi:10.3389/fneur.2017.00385
32. Ichinose Y, Miwa M, Onohara A, et al. Characteristic MRI findings in beta-propeller
protein-associated neurodegeneration (BPAN). Neurol Clin Pract. Apr 2014;4(2):175-177.
doi:10.1212/01.CPJ.0000437694.17888.9b
33. Verhoeven WM, Egger JI, Koolen DA, et al. Beta-propeller protein-associated neurodegeneration
(BPAN), a rare form of NBIA: novel mutations and neuropsychiatric phenotype in three adult
patients. Parkinsonism Relat Disord. Mar 2014;20(3):332-6. doi:10.1016/j.parkreldis.2013.11.019
34. Zhang L, Malhado-Chang N, Shankar S, Hagerman R. Autistic parkinsonism: NBIA with
mosaic WDR45 mutation and datscan positive dopa-responsiveness. Neurology. 2019;92(15
2
101